Zolk Oliver, Jacobi Johannes, Pahl Andreas, Fromm Martin F, Schmieder Roland E
Institute of Clinical and Experimental Pharmacology and Toxicology, University of Erlangen-Nuremberg, Erlangen, Germany.
Pharmacogenet Genomics. 2007 Feb;17(2):137-44. doi: 10.1097/01.fpc.0000239969.46594.d0.
Aldosterone plays a major role in the development of both hypertension and heart failure. As aldosterone is a substrate of the ABCB1 (P-glycoprotein) efflux transporter, whose expression and activity has been shown to be linked to the ABCB1 3435C-->T polymorphism, we tested the impact of the ABCB1 3435C-->T polymorphism on aldosterone disposition, blood pressure, cardiac structure, and kidney function.
A homogenous group of 116 young, white male Caucasian individuals with normal or mildlyto moderately elevated, but never treated blood pressure was included. Blood pressure was compared between individuals with ABCB1 3435 CC, CT, and TT genotypes. Moreover, genotype-dependent differences in basal and angiotensin II-stimulated serum aldosterone, cardiac structure, and kidney function were evaluated.
Of the 116 volunteers, 35 had the CC, 51 the CT and 30 the TT genotype. At baseline, no significant genotype-dependent differences in serum aldosterone were observed. After infusion of angiotensin II, the increase in aldosterone serum concentration was significantly higher in the TT group than that in the CT and CC groups (CC +11+/-35, CT +18+/-48, TT +45+/-50 pg/ml, P=0.012). Systolic and diastolic blood pressure, left ventricular structure, and function and baseline renal function were not significantly different. After additional oral sodium load (5 g/day over 1 week) urinary sodium excretion was found to be increased in individuals with the CC or CT genotype only but not in those with the TT genotype (CC +71+/-83, CT +52+/-114, TT -11+/-98 mmol/day, P=0.005).
The present study demonstrates that the ABCB1 3435 genotype affects angiotensin II-stimulated serum aldosterone levels and salt-stimulated urinary sodium excretion. Although blood pressure and cardiac structure were unchanged in this young study population, our findings indicate a new link between MDR1 genotype and the aldosterone system in humans.
醛固酮在高血压和心力衰竭的发展过程中起主要作用。由于醛固酮是ABCB1(P-糖蛋白)外流转运体的底物,其表达和活性已被证明与ABCB1 3435C→T多态性有关,我们测试了ABCB1 3435C→T多态性对醛固酮处置、血压、心脏结构和肾功能的影响。
纳入116名年轻的白人男性高加索人,他们血压正常或轻度至中度升高,但从未接受过治疗。比较了ABCB1 3435 CC、CT和TT基因型个体之间的血压。此外,还评估了基础和血管紧张素II刺激的血清醛固酮、心脏结构和肾功能的基因型依赖性差异。
116名志愿者中,35人具有CC基因型,51人具有CT基因型,30人具有TT基因型。在基线时,未观察到血清醛固酮有显著的基因型依赖性差异。输注血管紧张素II后,TT组醛固酮血清浓度的升高显著高于CT组和CC组(CC组升高11±35,CT组升高18±48,TT组升高45±50 pg/ml,P=0.012)。收缩压和舒张压、左心室结构和功能以及基线肾功能无显著差异。额外口服钠负荷(1周内每天5克)后,发现只有CC或CT基因型个体的尿钠排泄增加,而TT基因型个体则没有(CC组增加71±83,CT组增加52±114,TT组减少11±98 mmol/天,P=0.005)。
本研究表明,ABCB1 3435基因型影响血管紧张素II刺激的血清醛固酮水平和盐刺激的尿钠排泄。尽管在这个年轻的研究人群中血压和心脏结构没有变化,但我们的研究结果表明了人类中MDR1基因型与醛固酮系统之间的新联系。